{"transactions":[{"id":2607255,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-11T13:14:29.000Z","date":"2021-08-09","kind":"purchase","acquired":true,"shares":639,"price":3.62,"value":2313.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2021."}],"balance_after":639,"source":{"system":"sec-edgar","filing":"0001209191-21-050758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121050758/doc4.xml","form_type":"4"}},{"id":2739811,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-26T21:38:00.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests and will become exercisable monthly over 48 months, with 25% of the shares vesting on the 12-month anniversary of the date hereof, and the remainder vesting monthly thereafter at the rate of 1/48th of the total number of shares."}],"balance_after":25000,"derivative":{"exercise_price":5.89,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-028355","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121028355/doc4a.xml","form_type":"4/A","original_submission_date":"2021-02-10"}},{"id":2843663,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-23T02:33:19.000Z","date":"2021-02-09","kind":"purchase","acquired":true,"shares":1670,"price":4.81,"value":8032.7,"ownership":{"direct":false,"nature":"By Howard and Gillian Levy Revocable Trust dated November 21, 1994"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2021."}],"balance_after":23390,"source":{"system":"sec-edgar","filing":"0001209191-21-013036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121013036/doc4.xml","form_type":"4"}},{"id":2869697,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-10T22:50:04.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests over a four (4) year period on each monthly anniversary commencing February 8, 2021."}],"balance_after":25000,"derivative":{"exercise_price":5.89,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-009347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121009347/doc4.xml","form_type":"4"}},{"id":3060561,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-12T20:11:44.000Z","date":"2020-08-10","kind":"purchase","acquired":true,"shares":1768,"price":4.81,"value":8504.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 10, 2020."}],"balance_after":4268,"source":{"system":"sec-edgar","filing":"0001209191-20-046347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120046347/doc4.xml","form_type":"4"}},{"id":3205942,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-17T20:23:16.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":2500,"price":4.0526,"value":10131.5,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-20-019584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120019584/doc4.xml","form_type":"4"}},{"id":3277579,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-13T01:28:17.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":1358,"price":6.23,"value":8460.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan (\"ESPP\") on February 10, 2020."}],"balance_after":1358,"source":{"system":"sec-edgar","filing":"0001209191-20-009040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120009040/doc4.xml","form_type":"4"}},{"id":3301460,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-27T19:00:12.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests over a four (4) year period on each monthly anniversary commencing January 23, 2020."}],"balance_after":45000,"derivative":{"exercise_price":6.85,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-004966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120004966/doc4.xml","form_type":"4"}},{"id":3515578,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-22T16:23:55.000Z","date":"2019-05-20","kind":"exercise","acquired":false,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":81218,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001209191-19-031947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119031947/doc4.xml","form_type":"4"}},{"id":3515577,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-22T16:23:55.000Z","date":"2019-05-21","kind":"gift","acquired":false,"shares":16094,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Howard and Gillian Levy Revocable Trust dated November 21, 1994"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 21, 2019, the reporting person transferred 16,094 directly owned shares of Company common stock to the Howard and Gillian Levy Revocable Trust dated November 21, 1994, of which the insider and his wife are trustees and beneficiaries."}],"balance_after":16094,"source":{"system":"sec-edgar","filing":"0001209191-19-031947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119031947/doc4.xml","form_type":"4"}},{"id":3515576,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-22T16:23:55.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":4400,"price":4.63,"value":20372.0,"ownership":{"direct":true},"balance_after":16094,"source":{"system":"sec-edgar","filing":"0001209191-19-031947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119031947/doc4.xml","form_type":"4"}},{"id":3660808,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-13T22:00:36.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":2485,"price":7.04,"value":17494.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan (\"ESPP\") on February 11, 2019."}],"balance_after":11867,"source":{"system":"sec-edgar","filing":"0001209191-19-009704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119009704/doc4.xml","form_type":"4"}},{"id":3677853,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T21:53:03.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":93500,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-19-006862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119006862/doc4.xml","form_type":"4"}},{"id":3677852,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-04T21:53:03.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":1500,"price":4.63,"value":6945.0,"ownership":{"direct":true},"balance_after":9382,"source":{"system":"sec-edgar","filing":"0001209191-19-006862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119006862/doc4.xml","form_type":"4"}},{"id":3685542,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-28T23:54:33.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests over a four (4) year period on each monthly anniversary commencing January 24, 2019."}],"balance_after":35000,"derivative":{"exercise_price":7.97,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-005666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119005666/doc4.xml","form_type":"4"}},{"id":3752247,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-27T22:01:53.000Z","date":"2018-11-26","kind":"exercise","acquired":false,"shares":149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":87118,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":149},"source":{"system":"sec-edgar","filing":"0001209191-18-060006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118060006/doc4.xml","form_type":"4"}},{"id":3752246,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-27T22:01:53.000Z","date":"2018-11-26","kind":"exercise","acquired":true,"shares":149,"price":4.63,"value":689.87,"ownership":{"direct":true},"balance_after":7709,"source":{"system":"sec-edgar","filing":"0001209191-18-060006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118060006/doc4.xml","form_type":"4"}},{"id":3761728,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-16T22:56:38.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":87267,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":173},"source":{"system":"sec-edgar","filing":"0001209191-18-059044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118059044/doc4.xml","form_type":"4"}},{"id":3761727,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-16T22:56:38.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":173,"price":11,"value":1903.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018."}],"balance_after":7560,"source":{"system":"sec-edgar","filing":"0001209191-18-059044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118059044/doc4.xml","form_type":"4"}},{"id":3761726,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-16T22:56:38.000Z","date":"2018-11-16","kind":"exercise","acquired":true,"shares":173,"price":4.63,"value":800.99,"ownership":{"direct":true},"balance_after":7733,"source":{"system":"sec-edgar","filing":"0001209191-18-059044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118059044/doc4.xml","form_type":"4"}},{"id":3857004,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T21:47:34.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award vests monthly over four (4) years starting June 13, 2018."}],"balance_after":35000,"derivative":{"exercise_price":9.68,"expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-18-044788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118044788/doc4.xml","form_type":"4"}},{"id":3945743,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-04T20:58:17.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":7560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing June 15, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Due to clerical error, the expiration date of the grant was erroneously reported on the Form 4 filed July 13, 2017 as \"07/11/2017\". This filing corrects that error."}],"balance_after":87440,"derivative":{"exercise_price":4.63,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":7560},"source":{"system":"sec-edgar","filing":"0001209191-18-028135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118028135/doc4.xml","form_type":"4"}},{"id":3945742,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-04T20:58:17.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":7560,"price":4.63,"value":35002.8,"ownership":{"direct":true},"balance_after":7560,"source":{"system":"sec-edgar","filing":"0001209191-18-028135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118028135/doc4.xml","form_type":"4"}},{"id":4099503,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option(Right to Buy)","published_at":"2018-01-16T20:42:22.000Z","date":"2018-01-12","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing January 12, 2018."}],"balance_after":33000,"derivative":{"exercise_price":15.13,"expiration_date":"2028-01-12","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0000899243-18-001062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000089924318001062/doc4.xml","form_type":"4"}},{"id":4258461,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":136400,"kind":"person","name":"Levy Howard","position":1,"cik":"0001672333","reported_name":"Levy Howard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-12T20:48:03.000Z","date":"2017-07-11","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests monthly over a period of four years commencing June 15, 2017."}],"balance_after":95000,"derivative":{"exercise_price":4.63,"expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-17-044902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117044902/doc4.xml","form_type":"4"}}]}